Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette(Scripps Clinic), Nadeem Anwar, Manal F. Abdelmalek(Mayo Clinic), Andrew Scanga(Vanderbilt University Medical Center), Parvez Mantry(Methodist Dallas Medical Center), Brett E. Fortune(Montefiore Medical Center), Nikolaos Pyrsopoulos(Rutgers, The State University of New Jersey), Ethan M. Weinberg(California University of Pennsylvania), Marwan Ghabril, J. E. M. Robinson(Centre National de la Recherche Scientifique), Edward Mena(California Liver Research Institute), George Therapondos, Aasim Sheikh(GI Specialists of Georgia (United States)), John M. Vierling(Baylor College of Medicine), Kathleen E. Corey, Charles Landis(University of Washington), Kathryn Jean Lucas(Lucas Research), Jean L. Chan(Hadassah Medical Center), Hugo E. Vargas(Mayo Clinic in Arizona), Don C. Rockey(Medical University of South Carolina), Mazen Noureddin(Methodist Hospital), Andrew S. deLemos, Nicole M. Wedick(Brigham and Women's Hospital), Michael P. Curry, Danielle Brandman(University of California, San Francisco), Amy Stratton, Viviana Figueroa-Diaz, Kiran Bambha(Mayo Clinic), Douglas A. Simonetto(Mayo Clinic), B. Freilich(Kansas City Research Institute), Paul J. Thuluvath(University of Maryland, Baltimore), Victor Ankoma‐Sey, Eric Lawitz(The University of Texas at San Antonio Health Science Center), H. Tatum, Lance L. Stein, Nyingi Kemmer(Tampa General Hospital), R. Todd Frederick(California Pacific Medical Center), David Hagerty(Bristol-Myers Squibb (United States)), Reem Ghalib(Clinical Research Institute), Kris V. Kowdley(Liver Institute Northwest), Kimberly Brown(Henry Ford Health System), William Lee(Drexel University), Miguel Rodriguez, David Bernstein(Conatus Pharmaceuticals (United States)), Zeid Kayali(Arrowhead Regional Medical Center), Guy Neff, Mark McKenzie, Bal Raj Bhandari(Ironwood Pharmaceuticals (United States)), Kalyan Ram Bhamidimarri(University of Miami), Mitchell L. Shiffman(Bon Secours Health System)
Cited by 62
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k